Published in Proc Natl Acad Sci U S A on July 21, 2010
Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science (2010) 1.59
Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis. Blood (2013) 1.53
Allostery in the Hsp70 chaperone proteins. Top Curr Chem (2013) 1.52
Conformational selection in trypsin-like proteases. Curr Opin Struct Biol (2012) 1.20
Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci U S A (2011) 1.12
Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states. J Biol Chem (2010) 1.08
Allostery in trypsin-like proteases suggests new therapeutic strategies. Trends Biotechnol (2011) 1.07
Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins. Nat Struct Mol Biol (2011) 0.99
The dynamic structure of thrombin in solution. Biophys J (2012) 0.98
Ligand binding to anion-binding exosites regulates conformational properties of thrombin. J Biol Chem (2013) 0.93
The transition of prothrombin to thrombin. J Thromb Haemost (2013) 0.93
Essential role of conformational selection in ligand binding. Biophys Chem (2013) 0.90
Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa. J Phys Chem B (2010) 0.89
NMR reveals novel mechanisms of protein activity regulation. Protein Sci (2011) 0.89
Thermodynamic compensation upon binding to exosite 1 and the active site of thrombin. Biochemistry (2011) 0.88
Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector. Proc Natl Acad Sci U S A (2012) 0.88
Correlated motions and residual frustration in thrombin. J Phys Chem B (2013) 0.87
Meizothrombin is an unexpectedly zymogen-like variant of thrombin. J Biol Chem (2012) 0.86
Specificity of a protein-protein interface: local dynamics direct substrate recognition of effector caspases. Proteins (2013) 0.86
GpIbα interacts exclusively with exosite II of thrombin. J Mol Biol (2013) 0.84
Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold. J Biol Chem (2015) 0.83
Dynamics Govern Specificity of a Protein-Protein Interface: Substrate Recognition by Thrombin. PLoS One (2015) 0.82
Thrombin a-chain: activation remnant or allosteric effector? Thrombosis (2010) 0.80
Promiscuous and specific recognition among ephrins and Eph receptors. Biochim Biophys Acta (2014) 0.79
Molecular Mechanisms of Enzyme Activation by Monovalent Cations. J Biol Chem (2016) 0.79
Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation. Blood (2017) 0.79
Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction. Blood (2011) 0.78
Structural transitions during prothrombin activation: On the importance of fragment 2. Biochimie (2015) 0.78
Cell-laden microfluidic microgels for tissue regeneration. Lab Chip (2016) 0.78
Coagulation factor XII protease domain crystal structure. J Thromb Haemost (2015) 0.77
Identifying and Visualizing Macromolecular Flexibility in Structural Biology. Front Mol Biosci (2016) 0.77
Structure and behavior of human α-thrombin upon ligand recognition: thermodynamic and molecular dynamics studies. PLoS One (2011) 0.77
Ensemble refinement shows conformational flexibility in crystal structures of human complement factor D. Acta Crystallogr D Biol Crystallogr (2014) 0.77
The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin. PLoS One (2013) 0.76
Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function. PLoS One (2016) 0.75
NMR reveals a dynamic allosteric pathway in thrombin. Sci Rep (2017) 0.75
Isothermal titration calorimetry of ion-coupled membrane transporters. Methods (2015) 0.75
Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity. J Biol Chem (2015) 0.75
Direct and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics. Sci Rep (2016) 0.75
Loop Electrostatics Asymmetry Modulates the Preexisting Conformational Equilibrium in Thrombin. Biochemistry (2016) 0.75
Through-bond effects in the ternary complexes of thrombin sandwiched by two DNA aptamers. Nucleic Acids Res (2016) 0.75
Proton bridging in the interactions of thrombin with hirudin and its mimics. Biochemistry (2013) 0.75
Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat Struct Mol Biol (2017) 0.75
Noncanonical Proteolytic Activation of Human Prothrombin by Subtilisin from Bacillus subtilis may Shift the Procoagulant-Anticoagulant Equilibrium Toward Thrombosis. J Biol Chem (2017) 0.75
Induced fit is a special case of conformational selection. Biochemistry (2017) 0.75
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. Nature (1964) 3.73
WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. Science (1964) 3.44
The protein C pathway. Chest (2003) 3.14
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature (2000) 2.04
Thrombin is a Na(+)-activated enzyme. Biochemistry (1992) 1.87
Directing thrombin. Blood (2005) 1.85
Thrombin. Mol Aspects Med (2008) 1.80
Molecular recognition mechanisms of thrombin. J Thromb Haemost (2005) 1.66
Solvent accessibility of the thrombin-thrombomodulin interface. J Mol Biol (2001) 1.58
The active site of thrombin is altered upon binding to thrombomodulin. Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J Biol Chem (1991) 1.44
NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. J Med Chem (1997) 1.41
Molecular recognition by thrombin. Role of the slow-->fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components. J Mol Biol (1994) 1.33
The molecular environment of the Na+ binding site of thrombin. Biophys Chem (1997) 1.29
Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Arterioscler Thromb Vasc Biol (2006) 1.24
The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. J Biol Chem (1992) 1.21
Crystal structure of wild-type human thrombin in the Na+-free state. Biochem J (2005) 1.18
Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates. J Biol Chem (1991) 1.15
Crystal structure of the complex between thrombin and the central "E" region of fibrin. Proc Natl Acad Sci U S A (2004) 1.13
Sequence-specific NMR assignment of proteins by global fragment mapping with the program MAPPER. J Biomol NMR (2000) 1.12
Large heat capacity change in a protein-monovalent cation interaction. Biochemistry (1996) 1.10
Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin. Proc Natl Acad Sci U S A (2003) 1.07
Kinetic pathway for the slow to fast transition of thrombin. Evidence of linked ligand binding at structurally distinct domains. J Biol Chem (1997) 1.06
Thrombomodulin tightens the thrombin active site loops to promote protein C activation. Biochemistry (2005) 1.04
Allosteric changes in solvent accessibility observed in thrombin upon active site occupation. Biochemistry (2004) 1.04
Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation. J Biol Chem (2007) 1.01
Mechanism of Na(+) binding to thrombin resolved by ultra-rapid kinetics. Biophys Chem (2007) 1.01
Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I. Biochemistry (2001) 0.98
High-level bacterial expression and 15N-alanine-labeling of bovine trypsin. Application to the study of trypsin-inhibitor complexes and trypsinogen activation by NMR spectroscopy. Biochemistry (2001) 0.97
Thrombomodulin increases the rate of thrombin inhibition by BPTI. Biochemistry (1998) 0.94
How Na+ activates thrombin--a review of the functional and structural data. Biol Chem (2008) 0.92
Molecular basis of thrombomodulin activation of slow thrombin. J Thromb Haemost (2009) 0.91
Slow thrombin is zymogen-like. J Thromb Haemost (2009) 0.90
Cofactor-induced and mutational activity enhancement of coagulation factor VIIa. Cell Mol Life Sci (2008) 0.87
The complete folding pathway of a protein from nanoseconds to microseconds. Nature (2003) 3.61
Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature (2008) 2.88
LC3C, bound selectively by a noncanonical LIR motif in NDP52, is required for antibacterial autophagy. Mol Cell (2012) 2.41
Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat Struct Mol Biol (2010) 2.31
Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol (2004) 2.26
Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. Nat Struct Mol Biol (2010) 2.15
Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc Natl Acad Sci U S A (2007) 2.09
OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell (2013) 2.05
Molecular mechanism of the interaction between MDM2 and p53. J Mol Biol (2002) 2.03
FtsA forms actin-like protofilaments. EMBO J (2012) 2.00
Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev (2011) 1.89
Directing thrombin. Blood (2005) 1.85
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol (2003) 1.76
Crystal structure of thrombin bound to heparin. J Biol Chem (2004) 1.61
Core domain interactions in full-length p53 in solution. Proc Natl Acad Sci U S A (2006) 1.59
Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J (2006) 1.59
A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants. Proc Natl Acad Sci U S A (2002) 1.58
Solution structure of p53 core domain: structural basis for its instability. Proc Natl Acad Sci U S A (2006) 1.53
Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis. Blood (2013) 1.53
The denatured state of Engrailed Homeodomain under denaturing and native conditions. J Mol Biol (2003) 1.51
Characterization of the p53-rescue drug CP-31398 in vitro and in living cells. Oncogene (2002) 1.51
Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc Natl Acad Sci U S A (2002) 1.46
Molecular basis of α1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer. EMBO Rep (2011) 1.37
Serpins flex their muscle: I. Putting the clamps on proteolysis in diverse biological systems. J Biol Chem (2010) 1.32
Assembly, analysis and architecture of atypical ubiquitin chains. Nat Struct Mol Biol (2013) 1.27
Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Arterioscler Thromb Vasc Biol (2006) 1.24
Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL. J Biol Chem (2007) 1.23
Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding. J Mol Biol (2002) 1.22
Regulation of DNA binding of p53 by its C-terminal domain. J Mol Biol (2004) 1.22
Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein. J Biol Chem (2006) 1.18
Crystal structure of wild-type human thrombin in the Na+-free state. Biochem J (2005) 1.18
CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90. Proc Natl Acad Sci U S A (2002) 1.17
Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery. J Biol Chem (2004) 1.17
Serpins flex their muscle: II. Structural insights into target peptidase recognition, polymerization, and transport functions. J Biol Chem (2010) 1.14
Crystal structure of antithrombin in a heparin-bound intermediate state. Biochemistry (2003) 1.09
Hydrophobic core fluidity of homologous protein domains: relation of side-chain dynamics to core composition and packing. Biochemistry (2004) 1.08
Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states. J Biol Chem (2010) 1.08
Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex. Proc Natl Acad Sci U S A (2009) 1.07
The malignant brain tumor repeats of human SCML2 bind to peptides containing monomethylated lysine. J Mol Biol (2008) 1.07
Modulation of binding of DNA to the C-terminal domain of p53 by acetylation. Structure (2005) 1.06
Helix D elongation and allosteric activation of antithrombin. J Biol Chem (2001) 1.05
Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation. J Biol Chem (2006) 1.05
Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer. J Mol Biol (2011) 1.04
Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2). J Biol Chem (2006) 1.04
Serpin polymerization is prevented by a hydrogen bond network that is centered on his-334 and stabilized by glycerol. J Biol Chem (2003) 1.04
Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s. J Immunol (2012) 1.03
How small peptides block and reverse serpin polymerisation. J Mol Biol (2004) 1.03
The critical role of hinge-region expulsion in the induced-fit heparin binding mechanism of antithrombin. J Mol Biol (2009) 1.02
HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358. Retrovirology (2013) 1.01
Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex. Proc Natl Acad Sci U S A (2008) 0.98
Heparin-induced substrate behavior of antithrombin Cambridge II. Blood (2003) 0.94
Loop-sheet mechanism of serpin polymerization tested by reactive center loop mutations. J Biol Chem (2010) 0.94
An ensemble view of thrombin allostery. Biol Chem (2012) 0.94
Crystal structures of engrailed homeodomain mutants: implications for stability and dynamics. J Biol Chem (2003) 0.94
Structure of native protein C inhibitor provides insight into its multiple functions. J Biol Chem (2007) 0.93
The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism. J Biol Chem (2004) 0.90
Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69. EMBO Rep (2005) 0.90
Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein. Proc Natl Acad Sci U S A (2013) 0.89
Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide: implications for "mutant conformation". J Mol Biol (2004) 0.89
Allosteric activation of antithrombin critically depends upon hinge region extension. J Biol Chem (2004) 0.89
Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation. Proc Natl Acad Sci U S A (2009) 0.89
Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis. Circulation (2004) 0.88
The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import. Retrovirology (2013) 0.87
The influence of hinge region residue Glu-381 on antithrombin allostery and metastability. J Biol Chem (2003) 0.87
How serpins change their fold for better and for worse. Biochem Soc Symp (2003) 0.87
Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core. Protein Eng Des Sel (2009) 0.84
GpIbα interacts exclusively with exosite II of thrombin. J Mol Biol (2013) 0.84
Structural basis of p63α SAM domain mutants involved in AEC syndrome. FEBS J (2011) 0.84
Thrombin inhibition by serpins disrupts exosite II. J Biol Chem (2010) 0.83
Crystal structures of protease nexin-1 in complex with heparin and thrombin suggest a 2-step recognition mechanism. Blood (2012) 0.82
Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor. J Cell Biol (2007) 0.82
An essential role for the ATG8 ortholog LC3C in antibacterial autophagy. Autophagy (2013) 0.82
Paradoxical aggregation versus oligomerisation properties of mutant and wild-type huntingtin fragments. Exp Neurol (2006) 0.82
Role of conformational heterogeneity in domain swapping and adapter function of the Cks proteins. J Biol Chem (2005) 0.82
Solution structure of the FCS zinc finger domain of the human polycomb group protein L(3)mbt-like 2. Protein Sci (2009) 0.81
Diverse HIV viruses are targeted by a conformationally dynamic antiviral. Nat Struct Mol Biol (2012) 0.81
Solution structure of the BRK domains from CHD7. J Mol Biol (2007) 0.81
A Tyr346-->Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy. Br J Haematol (2002) 0.80
The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry. Nat Chem Biol (2013) 0.79
Allosteric activation of antithrombin is independent of charge neutralization or reversal in the heparin binding site. FEBS Lett (2006) 0.79
Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis. FEBS J (2006) 0.79
The heparin binding site of protein C inhibitor is protease-dependent. J Biol Chem (2008) 0.79
Molecular basis for modulation of the p53 target selectivity by KLF4. PLoS One (2012) 0.78
Antithrombin 'DREUX' (Lys 114Glu): a variant with complete loss of heparin affinity. Thromb Haemost (2002) 0.78
Homology model of human prothrombinase based on the crystal structure of Pseutarin C. Biol Chem (2014) 0.75
Targeting activated protein C to treat hemophilia. Curr Opin Hematol (2017) 0.75